All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date, and reported results Terminated | 2006-005678-36 | Oral alendronate for osteoporosis treatment in non-walking children with cerebral palsy | bad-data | |
Ongoing, reported early | 2007-005437-11 | Arthrose érosive des doigts : traitement par méthotrexate versus placebo- évaluation de l’action clinique et structurale (IRM dédiée)- Etude ADEM | not-yet-due | |
Ongoing | 2008-000239-17 | Use of MEOPA by elderly with dementia | not-yet-due | |
Reported results | 2008-003945-10 | ACTION OF THE AMANTADINE ON POST STROKE APHASIC PATIENTS LANGUAGE AND COMMUNICATION | 2014-04-04 | due-trials |
Reported results | 2008-004705-34 | PROTOCOLE D’ANALGESIE POST OPERATOIRE PAR INFILTRATION CONTINUE DE ROPIVACAINE DANS LES ARTHRODESES DU RACHIS LOMBAIRE | 2010-12-17 | due-trials |
Ongoing | 2009-012750-21 | Traitement des épidermolyses bulleuses dystrophiques héréditaires par l’épigallocatéchine-3-gallate oral (Polyphenon E®) | not-yet-due | |
Ongoing, reported early | 2009-013656-77 | Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin. | not-yet-due | |
No trial status on register, and reported results | 2010-022440-20 | Traitements of angioma plans of the child by laser to pulsed colouring agent and Timolol (Néogel 0,1%). | bad-data | |
No trial status on register, and reported results | 2010-024428-10 | Traitement des épidermolyses bulleuses simples de type Dowling Maera par l'érythromicine orale | bad-data | |
No trial status on register | 2012-004546-15 | Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up EVALUATION DE L’INCIDENCE DES EVENEMENTS INDESIRABLES EN POPULA... | bad-data | |
Not reported | 2014-003273-42 | Comparing a diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysfunction normotensive Comparaison d’un traitement diurétique au remplissage vas... | 2020-04-09 | due-trials |
Not reported | 2015-001614-94 | Hepatoprotective role of SMOFlipid® used in short-term parenteral nutrition in an Onco-Hematology Pediatric Population, pilot study Etude pilote du rôle hépatoprotecteur des SMOFlipid® en nutrition... | 2016-10-18 | due-trials |
Not reported | 2015-002298-39 | A national, multi-center study to evaluate the safety of long term treatment with teriflunomide 14 mg once daily in patients with a first clinical episode suggestive of multiple sclerosis in a long-te... | 2020-08-31 | due-trials |
Reported results | 2015-003944-38 | Treatment of the oral aphtose récidivante and idiopathique of the adult by probiotics Double-blind randomized interventional study versus placebo | 2019-05-02 | due-trials |
Ongoing | 2016-003329-40 | Neovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroid melanoma Prévention du glaucome néovasculaire par injections in... | not-yet-due | |
Other | 2017-001288-18 | ASIC channels and migraine disorders - Proof of concept study on the efficacy of Amiloride in prophylaxis of Migraine with Aura - APAM study Canaux ASIC et maladie migraineuse - Etude de preuve de ... | not-yet-due | |
Ongoing | 2017-004608-22 | Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinoma Study "PICABAS" Etude ouverte, prospective... | not-yet-due | |
Not reported | 2018-001371-20 | Study of the role of local treatments on the modulation of the microbiome in psoriatic skin Etude du rôle des traitements locaux sur la modulation du microbiome dans la peau psoriasique | 2019-03-07 | due-trials |
Completed, report not yet due | 2018-002476-40 | Personalized Medicine for Membranous Nephropathy PMMN | 2024-11-05 | not-yet-due |
Not reported | 2018-004072-35 | Study of the value of early treatment with an endothelin inhibitor (Bosentan) in patients with sudden blindness secondary to giant cell arteritis Etude de l’intérêt d’un traitement précoce par un... | 2023-07-26 | due-trials |
Ongoing | 2018-004300-19 | Target-controled infusion with propofol in the Emergency Department : a prospective study on 50 adult patients Sédation Intraveineuse à Objectif de Concentration (SIVOC) au propofol à l’accueil des... | not-yet-due | |
Ongoing | 2020-001542-19 | A 12-Week Multicentre, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Placebo in Patients > 6 years of age with EB simplex generalized severe | not-yet-due | |
Other | 2020-002127-10 | Evaluation of pain after intra-articular injections of botulinum toxin in carpometacarpal osteoarthritis of the thumb Évaluation de la douleur après injections intra-articulaires de toxine botuliqu... | not-yet-due | |
Ongoing | 2020-002912-34 | Treatment of bullous pemphigoid with avdoralimab (IPH5401), an anti-C5aR1 monoclonal antibody | not-yet-due | |
Other | 2020-003169-20 | Efficacy of dalbavancin during osteo-articular infections associated with hip and knee prostheses Efficacité de la dalbavancine au cours des infections ostéo-articulaires associées aux prothèses (I... | not-yet-due | |
Completed, report not yet due Terminated | 2021-000586-33 | Effect of molar sodium lactate infusion on cerebral hemodynamic in patients with severe subarachnoid hemorrhage: a multicenter double-blind randomized controlled study Effet du remplissage par lact... | 2024-06-07 | not-yet-due |
Other | 2021-006107-15 | LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB IN FRENCH PATIENTS WITH PROGRESSIVE MS: CONSONANCE EXTENSION STUDY | not-yet-due |